McBride: A £6m War Hole, Two Deals, and a Private-Label Wave That Keeps Rolling
A strong year with the shine knocked off
McBride's FY26 results land as a study in two stories moving at different speeds. The slow one — the structural march of private label — is intact and accelerating. The fast one — a fourth-quarter raw-material shock — did the damage. CEO Chris Smith was unusually blunt about the split: the past twelve months had been “hugely positive for the future of the group” — Christopher Ian Smith, Chief Executive Officer · 2026-09-16, yet the rapid inflation that followed the Middle East crisis “has taken the shine off a year of really strong strategic delivery” — Christopher Ian Smith, Chief Executive Officer · 2026-09-16.
The mechanism will be familiar to anyone who has followed this company. Inputs — chemicals, packaging, freight — spiked 12.2% in two months, a pace that took a full year to match in the 2021–22 episode. Adjusted operating profit came in at £59m, £7.1m below last year, and CFO Mark Strickland sized the war's hit precisely: “We estimate that the impact of the war was circa GBP 6 million on the financial year, which would have meant an adjusted operating profit of circa GBP 65 million” — Mark Strickland, Chief Financial Officer · 2026-09-16. This is a genuinely global theme, not a McBride quirk. The market's own top keywords for the spring quarter were dominated by high fuel costs and the Middle East conflict, with Iran conflict carrying heavy editorial momentum. McBride is riding the wave, not creating it.
What makes it more than a macro footnote is the response. Using the playbook from four years ago, the group went back to customers fast, using forward cost estimates to justify price rises — a phrase that has been the company's single highest-momentum keyword for two consecutive quarters. Chris's satisfaction lay less in the outcome than the tempo: they had “proved the model of being able to recover pricing and margins in a shorter window than we were able to do 4 years ago” — Christopher Ian Smith, Chief Executive Officer · 2026-09-16. The lag is real, but the dial is shorter.
The two deals that actually change the story
The quarter's real signal isn't the profit dip; it's the pair of deals that closed after the year-end. The Eurotab acquisition (completed 1 July) adds roughly €65m of top line — about a quarter more Unit Dosing revenue — bought at 4.6x, forecast to fall to 3.1x post-synergies. The Vestacy agreement is the bigger swing: a 5–8 year contract with the former Reckitt Essential Homes business that, at maturity, adds an estimated £170m of revenue by 2H FY28 and some 180 million units a year, mostly funded by the partner. Smith framed the strategic logic crisply: the deal will “take the group's ratio of contract manufacturing beyond the 25% strategic ambition we outlined in our 2024 Capital Markets Day” — Christopher Ian Smith, Chief Executive Officer · 2026-09-16.
Contrast this with the prior call, when management was still gesturing at intent. In February, Chris said the company wanted to get “contract manufacturing to be 25% of the business” — Christopher Ian Smith, Chief Executive Officer · 2026-02-26, and pushed back hard on valuation discipline: “we're not going to be out there paying 8x or 9x for anything” — Christopher Ian Smith, Chief Executive Officer · 2026-02-26. Both deals suggest they didn't have to. Acquisition of two Vestacy factories for nominal consideration, plus the Iberian footprint (Granollers, Porto Alto), is contract manufacturing scale bought cheaply.
Private label: a wave the whole market is surfing
Underneath the noise, the structural case strengthened. The group's market data show private-label share at an all-time high of 36.7% by volume at June '26 — “raising private label share in volume terms by 1 percentage point to 36.7% at June '26” — Christopher Ian Smith, Chief Executive Officer · 2026-09-16 — up 2.5 points over three years while brands have been flat. Lidl grew 20% over that period; Aldi, the largest customer, was softer. This isn't a McBride-only story, but the company is the largest private-label player in Europe, which is why the tape's faint exception is worth noting: the global cluster of private label offering names actually declined over the trailing year. The consumer trade-down thesis is winning on the shelf; it has not yet uniformly won in equity prices.
Look, we've seen a little bit of, I would say, positive momentum in the share price as a result of the announcements of those deals, perhaps the growth of the share price is in excess of the amount of EPS accretion that we would get. So that would imply some form of re-rating.
What changed — and why it matters
For a small-cap (£278m market cap) with a share price up roughly 60% over twelve months, the interesting question is whether the re-rating is deserved. Management's own read — that the market is pricing a re-rating, not just EPS accretion — is the honest version. The company has now done what it promised: it rebuilt the balance sheet (four years of debt reduction), then deployed £18m of shareholder returns, and then two growth deals inside three months.
The contrast with the broader tape is instructive. The single hottest global keyword in the spring quarter was Tariff Refund, a tax-driven windfall echoed by peers like Kirkland's and Vera Bradley. McBride's inflation is geopolitical and input-led, not tariff-led — a different animal that requires price negotiation rather than a refund cheque. That makes its recovery harder but its pricing power more proven when it lands.
The risks are legible. Net debt rose to £122.8m and will climb again as Eurotab and Vestacy funding beds in; exceptional costs step up to ~£12m in FY27; the price lag could repeat if the conflict persists. But the trajectory is clear: two deals, a record private-label share, and a management team that has now closed the gap between ambition and execution. The old frustration — Smith's insistence a year ago that “this business is not a 3% to 4% business. This is a 7% to 8% and an 8% to 10% business in EBITDA terms” — Christopher Ian Smith · 2025-09-18 — may finally be getting a hearing.